Info from IRISYS

We’re proud to share the wisdom of Dr. Jerry Yakatan, Chairman, CEO and founder of IRISYS, who has decades of experience with pharmaceutical development, clinical trial strategy and design, and regulatory affairs. Info from IRISYS includes the Yakatan Rules for Pharma R&D Efficiency, which are extracted from his popular seminar, “Where Have All the New Drugs Gone:  A Model for Improving the Efficiency and Costs of Pharmaceutical R&D.”

Info from IRISYS also presents insights from other members of our Leadership group, whose expertise spans all aspects of pharma discovery and development.

The Yakatan Rules for Pharma R&D Efficiency #2

November 2nd, 2017
Welcome to The Yakatan Rules blog, which shares the opinions of Dr. Jerry Yakatan, Chairman, CEO and founder of IRISYS. Please see Rule #1 – Establish small discovery teams led by “Drug Finders” Rule #2 – Assign responsibility & authority to teams Program identification Budget Hiring Funding “Feed & clothe” Program identification is the first – …

Continue Reading


Z-Endoxifen manufactured for the National Cancer Institute

September 11th, 2017
IRISYS is privileged to have manufactured capsules of Z-Endoxifen for the National Cancer Institute that made a major difference in the life of a cancer patient in a Mayo Clinic trial.  We invite you to watch the following brief video, which shows why researchers are encouraged by the early results for patients using Z-Endoxifen: Further …

Continue Reading


The Yakatan Rules for Pharma R&D Efficiency #1

September 4th, 2017
“…a man should share the passion and action of his time, at peril of being judged not to have lived”. – Oliver Wendell Holmes, Jr., 1884 (1841-1935). Welcome to The Yakatan Rules blog, which shares the opinions of Dr. Jerry Yakatan, Chairman, CEO and founder of IRISYS. To set the stage, over the last decade… …

Continue Reading